We use cookies on this site to enable your digital experience. By continuing to use this site, you are agreeing to our cookie policy. close

Lawmaker Needles FDA Over Avandia Vote Details

Law360 (October 29, 2007, 12:00 AM EDT) -- A U.S. senator is asking the U.S. Food and Drug Administration to respond to accounts that an internal drug safety oversight board voted earlier in October to keep GlaxoSmithKline’s diabetes drug...
To view the full article, register now.
Law360 Pro Say Podcast
Check out Law360's new podcast, Pro Say, which offers a weekly recap of both the biggest stories and hidden gems from the world of law.